Xing, J.; Chen, W.; Chen, K.; Zhu, S.; Lin, F.; Qi, Y.; Zhang, Y.; Han, S.; Rao, T.; Ruan, Y.;
et al. TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB. Cancers 2022, 14, 4809.
https://doi.org/10.3390/cancers14194809
AMA Style
Xing J, Chen W, Chen K, Zhu S, Lin F, Qi Y, Zhang Y, Han S, Rao T, Ruan Y,
et al. TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB. Cancers. 2022; 14(19):4809.
https://doi.org/10.3390/cancers14194809
Chicago/Turabian Style
Xing, Ji, Wu Chen, Kang Chen, Shaoming Zhu, Fangyou Lin, Yucheng Qi, Yunlong Zhang, Shangting Han, Ting Rao, Yuan Ruan,
and et al. 2022. "TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB" Cancers 14, no. 19: 4809.
https://doi.org/10.3390/cancers14194809
APA Style
Xing, J., Chen, W., Chen, K., Zhu, S., Lin, F., Qi, Y., Zhang, Y., Han, S., Rao, T., Ruan, Y., Zhao, S., Yu, W., & Cheng, F.
(2022). TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB. Cancers, 14(19), 4809.
https://doi.org/10.3390/cancers14194809